8VY4
Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy
External Resource: Annotation
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| Heavy Chain | IGHV1 | - | pca-asp-gly-asn-glu-glu-met | SAbDab (2024-08-30) | |
| Light Chain | IGKV1 | Kappa | pca-asp-gly-asn-glu-glu-met | SAbDab (2024-08-30) |
Protein Modification Annotation
| Modified Residue(s) | ||
|---|---|---|
| Chain | Residue(s) | Description |
| PCA | Parent Component: GLN : AA0031 : 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 | |
| PCA | Parent Component: GLN : AA0031 , AA0031 : 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 , 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 | |
